Background
Methods
Search strategy
Inclusion criteria
Methodological quality assessment
Data extraction
Data analysis
Results
Results of the search and characteristics of the included studies
Results of meta-analyses
Q1: are periodontitis and T2DM associated with each other?
Study | Evaluated PD related conditions | Definition of T2DM | Main conclusion and outcome |
---|---|---|---|
PD/non-PD | |||
Awuti 2012 [20] | Moderate PD: PPD ≤6 mm, or CAL of 3–4 mm; or possible presence of slight loose teeth (N = 98) Severe PD: PPD > 6 mm, or CAL ≥5 mm; or more than one loose tooth (N = 77) Control: non-PD (N = 509) | The 1999 WHO criteria and ADA standards | T2DM was more prevalent in moderate PD compared with no PD. Adjusted OR = 4.033, 95%CI 2.069–7.861 T2DM was more prevalent in severe PD compared with no PD. Adjusted OR = 2.313, 95%CI 1.042–5.137 |
Choi 2011 [22] | Top quintile category versus the bottom quintile CAL: Quintile 1 mean CAL = 0.2 mm (N = 2412) Quintile 5 mean CAL = 3.0 mm (N = 2453) | ADA criteria | T2DM was more prevalent in mean CAL 3.0 mm compared with mean CAL 0.2 mm. Adjusted OR = 4.77, 95%CI 2.69–8.46 |
Top quintile category versus the bottom quintile PPD: Quintile 1 mean PPD = 0.7 mm (N = 2451) Quintile 5 mean PPD = 2.2 mm (N = 2449) | T2DM was more prevalent in mean PPD 2.2 mm compared with mean PPD 0.7 mm. Adjusted OR = 1.63, 95%CI 1.10–2.42 | ||
Mohamed 2013 [37] | Chronic PD: at least one site with PPD of > 4 mm (N = 290) Control: non-PD (N = 157) | The 1999 WHO criteria | T2DM was more prevalent in chronic PD compared with non-PD. Adjusted OR = 4.07, 95%CI 1.74–9.49 |
Tooth mobility (N = 153) Control: without tooth mobility (N = 294) | T2DM was more prevalent in participants with tooth mobility compared with those without. Adjusted OR = 5.90, 95%CI 2.26–15.39 | ||
NOT > 21 teeth (N = 381) Control: NOT≤21 teeth (N = 66) | T2DM was less prevalent in participants with > 21teeth, with an OR of 0.23. Adjusted OR = 0.23, 95%CI 0.08–0.63 | ||
Nesse 2010 [40] | PD: CPITN score was ≥3, indicating PPD ≥4 mm (N = 217) Control:non-PD (N = 320) | Clinical examination; or medical record | T2DM was more prevalent in PD compared with non-PD. Adjusted OR = 4, 95%CI 1.03–15.3 |
Saito 2004 [46] | high portion category compared in the low portion CAL: Low mean CAL < 1.5 mm (N = 18) High mean CAL > 2.5 mm (N = 38) | The WHO criteria | T2DM was more prevalent in mean CAL > 2.5 mm compared with mean CAL 0.2 mm. Adjusted OR = 2.0, 95%CI 1.0–3.9 |
PPD: Low mean PPD < 1.3 mm (N = 18) High mean PPD > 2.0 mm (N = 32) | T2DM was more prevalent in mean PPD > 2.0 mm compared with < 1.3 mm. Adjusted OR = 2.6, 95%CI 1.3–5.0 | ||
Saito 2006 [45] | Mean alveolar bone loss (N = 131) Control: Low alveolar bone loss (N = 49) | The WHO criteria | Mean alveolar bone loss as a continuous variable showed a 1% increase in mean alveolar bone loss corresponded to a 6% increased prevalence of T2DM. Adjusted OR = 1.06 95%CI 1.00–1.12 |
T2DM/non-T2DM | |||
Kaur 2009 [25] | Top quartile compared with three lower quartiles LOT (Quartile 4 vs 1–3) | T2DM: After the age of 29; or insulin started > 1 year after disease onset (N = 310) Non-T2DM (N = 1858) | The OR for increase tooth loss was 1.65 times higher for the T2DM patients compared with non-T2DM participants. Adjusted OR = 1.65, 95%CI 1.13–2.39 |
Kowall 2015 [27] | PD: at least 2 non-adjacent teeth CAL ≥ 3 mm | Poorly controlled T2DM:HbA1c ≥7% (N = 64) Better controlled T2DM:HbA1c < 7% (N = 137) Non-T2DM (N = 2145) | PD was more prevalent in poorly controlled T2DM patients compared with non-T2DM participants, which was not statistically significant. Adjusted OR = 1.60 95%CI 0.55–4.63 The prevalence of PD showed no difference between better controlled T2DM patients and non-T2DM participants. Adjusted OR = 0.94 95%CI 0.52–1.67 |
Top quartile compared with three lower quartiles Mean CAL ≥ 4 mm (Quartile 4 vs 1–3) | The OR for CAL ≥ 4 mm was 1.36 times higher in poorly controlled T2DM patients compared with non-T2DM participants, which was not statistically significant. Adjusted OR = 1.36 95%CI 0.75–2.49 The prevalence of CAL ≥ 4 mm showed no difference between better controlled T2DM patients and non-T2DM participants. Adjusted OR = 0.94 95%CI 0.61–1.45 | ||
Top quartile compared with three lower quartiles Mean PPD (Quartile 4 vs 1–3) | The OR for top PPD was 1.31 times higher for the poorly controlled T2DM patients compared with non-T2DM participants, which was not statistically significant. Adjusted OR = 1.31 95%CI 0.75–2.30 The prevalence of mean PPD showed no difference between better controlled T2DM patients and non-T2DM participants. Adjusted OR = 1.13 95%CI 0.75–1.71 | ||
Lowest quartile compared with three higher quartiles NOT (Quartile1 vs 2–4) | The OR for NOT was 1.49 times higher in poorly controlled T2DM patients compared with non-T2DM participants, which was no statistically significant Adjusted OR = 1.49 95%CI 0.92–2.40 NOT showed no difference between better controlled T2DM patients and non-T2DM participants. Adjusted OR = 1.05 95%CI 0.74–1.50 | ||
Leung 2008 [30] | Chronic PD: CPI score of 4 in any one sextant (WHO, 1997). | T2DM: Clinical examination; or medical record (N = 364) Non-T2DM (N = 161) | PD was more prevalent in T2DM patients compared with non-T2DM participants. Adjusted OR = 1.84 95%CI 1.22–2.77 |
CAL ≥ 6 mm | The OR for CAL ≥ 6 mm was 1.71 times higher for T2DM patients compared with non-T2DM participants. Adjusted OR = 1.71, 95%CI 1.13–2.59 | ||
Nelson 1990 [39] | PD: < 24 teeth present;> 6 teeth with ≥25% bone loss and any tooth with ≥50% bone loss. | T2DM: OGTT ≥11.1 mmol/l (N = 720) Non-T2DM (N = 1553) | PD was more prevalent in T2DM patients compared with non-T2DM patients. Adjusted OR = 1.64, 95%CI 1.50–1.79 |
Saito 2005 [47] | Mean PPD ≥1.9 mm | T2DM: The WHO criteria (N = 27) Non-T2DM (N = 360) | The OR for PPD ≥ 1.9 mm was 1.4 times higher for the T2DM patients compared with non-T2DM participants, which was not statistically significant. Adjusted OR = 1.4 95%CI 0.6–3.2 |
Mean CAL ≥2.42 mm | The OR for CAL ≥ 2.42 mm was 1.5 times higher for the T2DM patients compared with non-T2DM participants, which was not statistically significant. Adjusted OR = 1.5 95%CI 0.7–3.2 | ||
Tanwir 2009 [51] | Missing fewer teeth | T2DM: Clinical examination; or medical record (N = 88) Non-T2DM (N = 80) | The OR for missing or fewer teeth was 2.3 times higher for the diabetic patients compared with non-T2DM patients. Adjusted OR = 2.3 95%CI 1.32–4.14 |
Tsai 2002 [52] | Severe PD: at least two sites CAL ≥6 mm at least one site PPD ≥5 mm | Poorly control T2DM:HbA1c ≥9% (N = 170) Better control T2DM:HbA1c < 9% (N = 260) Non-T2DM (N = 3841) | Severe PD was more prevalent in poorly controlled T2DM patients compared with non-T2DM participants. Adjusted OR = 2.90 95%CI 1.40–6.03 Severe PD was more prevalent in better controlled T2DM patients compared with non-T2DM participants, but was not statistically significant. Adjusted OR = 1.56 95%CI 0.90–2.68 |
Wang 2009 [53] | PD: The WHO 1997 criteria | T2DM: The 1999 WHO criteria (N = 193) Non-T2DM (N = 8468) | PD was more prevalent in T2DM patients compared with non-T2DM participants. Adjusted OR = 1.34 95%CI 1.07–1.74 |
Strength of association between periodontitis and T2DM
Directional adjusted T2DM prevalence (periodontitis versus nonperiodontitis)
Directional adjusted periodontitis prevalence (T2DM versus non-DM)
CAL level differences between T2DM and DM-free participants
PPD differences between T2DM and DM-free participants
NOT differences between T2DM and DM-free participants
LOT differences between T2DM and DM-free participants
Meta-regression for meta-analyses with huge heterogeneity
Q2: does T2DM increase the risk of developing periodontitis?
Study | Characteristics | Definition of outcome | Definition of exposure | Main conclusion and outcome |
---|---|---|---|---|
T2DM/non-T2DM | ||||
Chiu 2015 [62] | Taiwan, KCIS study 5y FU (2003–2008) | Binary variable PD: CPI ≥ 3 Non-PD: CPI < 3 | T2DM: FBG ≥ 126 mg/dl or self-reported T2DM (N = 57) Pre-diabetes: 100 ≤ FBG < 126 mg/dl (N = 297) None: FBG < 100 mg/dl (N = 4033) | T2DM led to a 95% elevated risk for incident PD. Adjusted HR = 1.95, 95%CI 1.22–3.13 Pre-diabetes led to a 25% elevated risk for incident PD. Adjusted HR = 1.25, 95%CI 1.00–1.57 |
Demmer 2012 [23] | Germany, SHIP study 5y FU (1997–2006) | Binary variable Tooth loss or not | T2DM: Self-reported age > 30 years old, or HbA1c ≥ 6.5%, timing of insulin therapy initiation > 1 year from diagnosis Controlled T2DM: HbA1c ≤ 7% (N = 80) Uncontrolled T2DM: HbA1c > 7% (N = 72) Control: no DM (N = 2280) | Controlled T2DM did not lead to an elevated risk for tooth loss. Adjusted RR = 1.01, 95%CI 0.79–1.28 Uncontrolled T2DM led to a 36% elevated risk for tooth loss. Adjusted RR = 1.36, 95%CI 1.11–1.67 |
Continuous variable Mean PPD change; Mean CAL change; | Controlled T2DM did not lead to an increased PPD and CAL change. Adjusted MD = 0.04 and 0.09 mm, p > 0.05 Uncontrolled T2DM led to a significant increase in PPD and CAL change. Adjusted MD = 0.18 and 0.37 mm, p < 0.05 | |||
Jimenez 2012 [65] | USA, HPFS study, 20y FU (1986-NA) | Binary variable PD: self-reported; Tooth loss: self-reported | T2DM: self-reported T2DM (N = 2285) Control: non-T2DM (N = 32,962) | T2DM led to a 29% elevated risk for incident PD. Adjusted RR = 1.29, 95%CI 1.13–1.47 T2DM led to a 9% elevated risk for incident tooth loss. Adjusted RR = 1.09, 95%CI 1.01–1.18 |
Morita 2012 [68] | Japan, 5y FU (1997–2006) | Binary variable PD: CPI ≥ 3 Non-PD: CPI < 3 | T2DM: HbA1c ≥ 6.5% (N = 150) Control: HbA1c < 6.5% (N = 5706) | T2DM led to a 17% elevated risk for incident PD. Adjusted RR = 1.17, 95%CI 1.01–1.36 |
Nelson 1990 [39] | USA, Pima Indians study, Mean 2.6y FU (1983–1989) | Binary variable PD: < 24 teeth present;> 6 teeth with ≥25% bone loss and any tooth with ≥50% bone loss. Non-PD: ≥24 teeth present; < 6 could have 25–50% bone loss and the rest < 25% bone loss | T2DM: OGTT ≥11.1 mM(N = 56) Control: no T2DM (N = 645) | T2DM led to a 160% elevated risk for incident PD. Adjusted RR = 2.57, 95%CI 1.0–6.6, p < 0.05 |
Taylor 1998 [69] | USA, Pima Indians study, Mean 2.3y FU (1.2–6.9 years) | Mean alveolar bone loss bone scores corresponded to bone loss of 0, 1to 24%, 25 to 49%, 50 to 74%, or > 75% | Diagnosed by OGTT (> 200 mg/dl) Better controlled T2DM: HbA1c ≤ 9% (N = 7) Poorer controlled T2DM: HbA1c > 9% (N = 14) Control: no T2DM (N = 338) | Better controlled T2DM led to a 120% elevated risk for alveolar bone loss progression, but was not statistically significant. Adjusted OR = 2.2, 95%CI 0.7–6.5, p = 0.175 Poorer controlled T2DM led to a 1040% elevated risk for alveolar bone loss progression. Adjusted OR = 11.4, 95%CI 2.5–53.3 |
PD/non-PD | ||||
Demmer 2008 [63] | USA, NHEFS study 17y FU (1971–1992) | T2DM: Death certificate; self-reported T2DM and received anti-diabetes medications; facility discharge diagnosis | Category of baseline periodontal index, control group was the participants with lowest RPI score | Compared to the control group, participants in the 1st or 2nd categories did not experience an increased OR of developing T2DM, whereas the odds increased sharply in the 3rd category (OR 2.08; P < 0.0001). The ORs in 4th (1.71; P = 0.003) and 5th (1.50; P = 0.06) categories abated but remained elevated and were not statistically significantly different from the odds for those in the 3rd category. |
PD: clinical diagnosed(N = 1662) Gingivitis: clinical diagnosed (N = 2135) Control: periodontium health (N = 3372) | PD led to a 50% elevated risk for incident T2DM. Adjusted OR≈1.50, 95%CI NA, p < 0.05 Gingivitis led to a 40% elevated risk for incident T2DM. Adjusted OR≈1.40, 95%CI NA, p < 0.05 | |||
Exposure: LOT 25–31 (N=NA) Control: LOT 0–8 (N=NA) | Loss more teeth at baseline led to a 70% elevated risk for incident T2DM. Adjusted OR≈1.70, 95%CI NA, p < 0.05 | |||
Ide 2010 [64] | Japan, 6.3y FU (2000–2007) | T2DM: FBG ≥ 125 mg/dl | Exposure1: CPI = 4 (N = 490) Exposure2: CPI = 3 (N = 2167) Control: CPI < 3 (N = 3191) | CPI = 4 led to a 28% elevated risk for incident T2DM, but was not statistically significant. Adjusted HR = 1.28, 95%CI 0.89–1.86 CPI = 3 did not led to an elevated risk for incident T2DM. Adjusted HR = 1.00, 95%CI 0.77–1.30 |
Exposure1: LOT> 3 (N = 748) Exposure2: 1 < LOT< 3 (N = 2265) Control: LOT = 0 (N = 2835) | Loss more than 3 teeth did not lead to an elevated risk for incident T2DM Adjusted HR = 0.98 95%CI 0.69–1.39 Loss 1 or 2 teeth did not lead to an elevated risk for incident T2DM. Adjusted HR = 1.02 95%CI 0.79–1.32 | |||
Kebede 2017 [66] | Germany, SHIP study 11.1y FU (1997–2012) | T2DM: Self-reported physician diagnosed T2DM or treatment with antidiabetic medication | Exposure: mean PPD 2.70–7.25 mm (N=NA) Control: mean PPD 0.95–1.97 mm (N=NA) | Deeper PPD did not lead to an elevated risk for incident T2DM. Adjusted incidence RR = 1.271 95% 0.782–2.065 |
Exposure: mean CAL 3.15–12.25 mm (N=NA) Control: mean CAL 0–1.15 mm (N=NA) | Higher CAL did not lead to an elevated risk for incident T2DM. Adjusted incidence RR = 0.819 95%CI 0.489–1.370 | |||
Miyawaki 2016 [67] | Japan, My health up Study, all male 5y FU (2004–2009) | T2DM: self-reported T2DM and received anti-diabetes medications, or based on clinical test (FBG ≥ 126 mg/dl or HbA1C ≥ 6.5%) | Exposure: self-reported tooth loosening (N = 262) Control: without tooth loosening (N = 2207) | Tooth loosening led to a 73% elevated risk for incident T2DM. Adjusted RR = 1.73, 95%CI 1.18–2.53 |
Exposure: self-reported gingival bleeding (N = 795) Control: without gingival bleeding (N = 1674) | Gingival bleeding led to a 23% elevated risk for incident T2DM, but was not statistically significant. Adjusted RR = 1.23, 95%CI 0.90–1.70 | |||
Morita 2012 [68] | Japan, 5y FU (1997–2006) | T2DM: HbA1c ≥ 6.5% | Exposure1: CPI = 4 (N = 1634) Exposure2: CPI = 3 (N = 4114) Control: CPI = 0 (N = 1647) | CPI = 4 led to a 245% elevated risk for incident T2DM. Adjusted RR = 3.45, 95%CI 1.08–11.02, p = 0.037 CPI = 3 led to a 145% elevated risk for incident T2DM, but was not statistically significant. Adjusted RR = 2.47, 95%CI 0.78–7.79, p = 0.122 |
Myllymki 2018 [70] | Finland, Cohort 1935 Survey, 15-18y FU (1990–2008) | T2DM: WHO 1995 criteria | Exposure1: PPD = 4-5 mm (N = 98) Exposure2: PPD > 6 mm (N = 91) Control: No deep pockets (N = 88) | Both two exposures did not increase the T2DM incidence. 4-5 mm PPD: adjusted RR = 1.32, 95%CI 0.69–2.53, p > 0.05 > 6 mm PPD: adjusted RR = 1.56, 95%CI 0.84–2.92, p > 0.05 |
Winning 2016 [71] | UK, PRIME study 7.8y FU (2001–2010) | T2DM: FBG ≥ 126 mg/dl and WHO criteria | Exposure1: moderate PD Exposure2: severe PD Moderate/severe PD total = 553 Control: No significant PD (N = 778) PD severity was based on CDC/AAP classification | Moderate PD led to a 53% elevated risk for developing T2DM, but was not statistically significant. Adjusted RR = 1.53, 95%CI 0.86–2.74, p > 0.05 Severe PD led to an 85% elevated risk for developing T2DM Adjusted RR = 1.85, 95%CI 1.06–3.22, p < 0.05 |